SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

USFDA completes inspection of Zydus Cadila’s arm’s manufacturing facility

06 Jun 2018 Evaluate

United States Food and Drug Administration (USFDA) has inspected Zydus Cadila’s wholly owned subsidiary, Alidac Pharmaceuticals’ manufacturing facility located at SEZ in Ahmedabad from May, 28 to June, 5 2018. At the end of the inspection there was no observation (483) issued. The site manufactures oncology injectables for the regulated markets.

Zydus Cadila is an innovative, global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare therapies.


Zydus Lifesciences Share Price

927.75 -1.10 (-0.12%)
22-Apr-2026 10:53 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1653.80
Dr. Reddys Lab 1215.95
Cipla 1228.20
Zydus Lifesciences 927.75
Lupin 2307.30
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×